1 alpha-hydroxyergocalciferol
Showing 1 - 25 of >10,000
Alpha-1 Antitrypsin Deficiency Trial in Gainesville (Alpha-1 Antitrypsin Genotype)
Recruiting
- Alpha-1 Antitrypsin Deficiency
- Alpha-1 Antitrypsin Genotype
-
Gainesville, FloridaUniversity of Florida
Nov 2, 2022
Alpha 1-Antitrypsin Deficiency Trial in Charleston (KB408 (Nebulization))
Not yet recruiting
- Alpha 1-Antitrypsin Deficiency
- KB408 (Nebulization)
-
Charleston, South CarolinaMedical University of South Carolina
Sep 20, 2023
Alpha-1 Antitrypsin Deficiency Trial in San Diego, Boston, Saint Louis (Liver Biopsy (Biopsy Group Only))
Recruiting
- Alpha-1 Antitrypsin Deficiency
- Liver Biopsy (Biopsy Group Only)
-
San Diego, California
- +2 more
Dec 13, 2022
DiabetesType 1 Trial (Placebo, Alpha Lipoic Acid 600 MG Oral Capsule)
Not yet recruiting
- Diabetes MellitusType 1
- Placebo
- Alpha Lipoic Acid 600 MG Oral Capsule
- (no location specified)
Jan 8, 2023
Alpha1-Antitrypsin Deficiency Trial in United States (Alpha-1 15%, Liquid Alpha1-Proteinase Inhibitor (Human))
Recruiting
- Alpha1-Antitrypsin Deficiency
- Alpha-1 15%
- Liquid Alpha1-Proteinase Inhibitor (Human)
-
Gainesville, Florida
- +5 more
Jan 13, 2023
Alpha1-Antitrypsin Deficiency Trial (Fazirsiran Injection)
Not yet recruiting
- Alpha1-Antitrypsin Deficiency
- Fazirsiran Injection
- (no location specified)
Jun 16, 2023
Alpha-1 Foundation DNA and Tissue Bank
Enrolling by invitation
- Alpha 1 Antitrypsin Deficiency
-
Gainesville, FloridaUniversity of Florida
Sep 19, 2022
Cardiac Functions in Type 1 Diabetes Mellitus
Not yet recruiting
- Diabetes Mellitus, Type 1
- +2 more
- transthoracic echocardiography
- (no location specified)
Nov 12, 2023
Type1diabetes, Hypoglycemia, Type 1 Diabetes Trial in Hellerup (Infusion of GIP[1-42], GIP[1-30] or )
Recruiting
- Type1diabetes
- +2 more
- Infusion of GIP[1-42], GIP[1-30] or placebo
-
Hellerup, Copenhagen, DenmarkCenter for Clinical Metabolic Research, Gentofte Hospital
Nov 17, 2023
Bronchiectasis Adult Trial in Dundee (Alpha 1-Proteinase Inhibitor 180mg/kg, Alpha 1-Proteinase Inhibitor 120mg/kg, Sodium
Not yet recruiting
- Bronchiectasis Adult
- Alpha 1-Proteinase Inhibitor 180mg/kg
- +2 more
-
Dundee, United KingdomNHS Tayside
Oct 12, 2022
NSCLC Trial in Guangzhou (Hypofractionated radiotherapy, induction chemo-immunotherapy, concurrent chemo)
Recruiting
- Non-small Cell Lung Cancer
- Hypofractionated radiotherapy
- +4 more
-
Guangzhou, Guangdong, ChinaSun yat-sen university cancer center
Nov 14, 2023
COPD Exacerbation Blood and Urine Biomarkers Study
Recruiting
- Chronic Obstructive Pulmonary Disease
- +2 more
-
New York, New YorkColumbia University Medical Center
Oct 11, 2022
HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1
Recruiting
- HLA-A2 Positive Cells Present
- Refractory Melanoma
- Alpha-type-1 Polarized Dendritic Cells
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 12, 2022
Intrauterine Growth Restriction in Pre-eclamptic Women
Not yet recruiting
- alpha1 Anti-trypsin
- +2 more
- Alpha1 -Antitrypsin level
- (no location specified)
Nov 18, 2022
COPD (COPD), Alpha1-Antitrypsin Deficiency Trial (ARALAST NP, Another Available A1PI)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease (COPD)
- Alpha1-Antitrypsin Deficiency
- ARALAST NP
- Another Available A1PI
- (no location specified)
Jul 18, 2022
Alpha 1-Antitrypsin Deficiency Trial in Gainesville, Charleston (ADVM-043)
Completed
- Alpha 1-Antitrypsin Deficiency
- ADVM-043
-
Gainesville, Florida
- +1 more
Aug 3, 2022
Alpha1-Antitrypsin Deficiency Trial (Fazirsiran Injection, Placebo)
Not yet recruiting
- Alpha1-Antitrypsin Deficiency
- Fazirsiran Injection
- Placebo
- (no location specified)
Feb 2, 2023
Coronary Artery Disease Trial in United Kingdom (BioMatrix Alpha)
Not yet recruiting
- Coronary Artery Disease
- BioMatrix Alpha
-
Birmingham, United Kingdom
- +5 more
Mar 23, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Biopsy
- +7 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Feb 23, 2023
Eosinophilic Esophagitis Trial (Alpha-proteinase inhibitor)
Not yet recruiting
- Eosinophilic Esophagitis
- Alpha-proteinase inhibitor
- (no location specified)
Aug 2, 2022
Type 1 Diabetes Trial in Edmonton (Alpha-1 Antitrypsin)
Completed
- Type 1 Diabetes Mellitus
- Alpha-1 Antitrypsin
-
Edmonton, Alberta, CanadaUniversity of Alberta
May 23, 2022
Alpha 1-Antitrypsin Deficiency, Genetic Disease Trial in United States
Recruiting
- Alpha 1-Antitrypsin Deficiency
- Genetic Disease
-
Birmingham, Alabama
- +9 more
Jul 4, 2022
Cytomegaloviral Infection, Hematopoietic and Lymphoid System Tumor Trial in Buffalo (Allogeneic Hematopoietic Stem Cell
Not yet recruiting
- Cytomegaloviral Infection
- Hematopoietic and Lymphoid System Neoplasm
- Allogeneic Hematopoietic Stem Cell Transplantation
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 16, 2022
Alpha-1-antitrypsin Deficiency Trial in Praha
Recruiting
- Alpha-1-antitrypsin Deficiency
-
Praha, Czech Republic, CzechiaThomayer university hospital
Dec 16, 2021